{"id":8685,"date":"2024-11-19T23:00:17","date_gmt":"2024-11-19T23:00:17","guid":{"rendered":"https:\/\/onpointlegalleads.com\/?p=8685"},"modified":"2025-04-04T14:54:20","modified_gmt":"2025-04-04T14:54:20","slug":"depo-provera-litigation-controversial-safety-warnings","status":"publish","type":"post","link":"https:\/\/onpointlegalleads.com\/mass-tort-leads\/depo-provera-litigation-controversial-safety-warnings\/","title":{"rendered":"Depo-Provera Litigation: Controversial Safety Warnings"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"8685\" class=\"elementor elementor-8685\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-4db668b elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"4db668b\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-0ce86b3\" data-id=\"0ce86b3\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-2a3e576 elementor-toc--minimized-on-tablet elementor-widget elementor-widget-table-of-contents\" data-id=\"2a3e576\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;headings_by_tags&quot;:[&quot;h2&quot;,&quot;h3&quot;,&quot;h4&quot;,&quot;h5&quot;],&quot;exclude_headings_by_selector&quot;:&quot;.elementor-widget-post-comments&quot;,&quot;marker_view&quot;:&quot;bullets&quot;,&quot;icon&quot;:{&quot;value&quot;:&quot;fas fa-angle-right&quot;,&quot;library&quot;:&quot;fa-solid&quot;},&quot;no_headings_message&quot;:&quot;No headings were found on this page.&quot;,&quot;minimize_box&quot;:&quot;yes&quot;,&quot;minimized_on&quot;:&quot;tablet&quot;,&quot;hierarchical_view&quot;:&quot;yes&quot;,&quot;min_height&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;min_height_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;min_height_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]}}\" data-widget_type=\"table-of-contents.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-toc__header\">\n\t\t\t\t\t\t<h4 class=\"elementor-toc__header-title\">\n\t\t\t\tTable of Contents\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-toc__toggle-button elementor-toc__toggle-button--expand\" role=\"button\" tabindex=\"0\" aria-controls=\"elementor-toc__2a3e576\" aria-expanded=\"true\" aria-label=\"Open table of contents\"><i aria-hidden=\"true\" class=\"fas fa-chevron-down\"><\/i><\/div>\n\t\t\t\t<div class=\"elementor-toc__toggle-button elementor-toc__toggle-button--collapse\" role=\"button\" tabindex=\"0\" aria-controls=\"elementor-toc__2a3e576\" aria-expanded=\"true\" aria-label=\"Close table of contents\"><i aria-hidden=\"true\" class=\"fas fa-chevron-up\"><\/i><\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<div id=\"elementor-toc__2a3e576\" class=\"elementor-toc__body\">\n\t\t\t<div class=\"elementor-toc__spinner-container\">\n\t\t\t\t<i class=\"elementor-toc__spinner eicon-animation-spin eicon-loading\" aria-hidden=\"true\"><\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c490ace elementor-widget elementor-widget-text-editor\" data-id=\"c490ace\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>At On Point Legal Leads, we specialize in providing law firms with the highest quality Depo-Provera litigation\u00a0<a href=\"https:\/\/onpointlegalleads.com\/mass-tort-leads\/\" target=\"_blank\" rel=\"noopener\">mass tort leads<\/a> and mass tort retainers leads. Our commitment to connecting affected individuals with experienced legal representation has positioned us at the forefront of this emerging litigation.<\/p><p>Let&#8217;s dive into the details of this significant health and legal issue.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-75cfac1 elementor-widget elementor-widget-heading\" data-id=\"75cfac1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Depo-Provera Litigation and International Warning Disparities <\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f747448 elementor-widget elementor-widget-text-editor\" data-id=\"f747448\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>\u00a0A troubling aspect of the Depo-Provera situation has emerged regarding Pfizer&#8217;s varying approach to safety warnings across different regions. While the company included specific warnings about meningioma risks in their European product labels and provided some degree of warning in Canada, U.S. consumers were notably left without similar cautionary information.\u00a0<\/p><p>This discrepancy in warning labels has become a central issue in pending litigation, raising questions about the company&#8217;s obligation to maintain consistent safety communications across all markets.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2418510 elementor-widget elementor-widget-heading\" data-id=\"2418510\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Severity of Health Impacts<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-581b270 elementor-widget elementor-widget-text-editor\" data-id=\"581b270\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>The primary health concern centers on the drug&#8217;s potential to cause <a href=\"https:\/\/www.cancer.gov\/rare-brain-spine-tumor\/tumors\/meningioma\" target=\"_blank\" rel=\"noopener\">meningiomas<\/a> &#8211; serious brain tumors that can have life-altering consequences. These tumors, while often benign, can still cause significant health complications depending on their location and size. Some patients require extensive surgical intervention, radiation therapy, or other intensive treatments, leading to substantial medical expenses and potential long-term health effects. These diagnoses and respective burdens are a centerpoint for\u00a0<a href=\"https:\/\/onpointlegalleads.com\/mass-tort-leads\/\" target=\"_blank\" rel=\"noopener\">mass tort leads<\/a>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7ca8185 elementor-widget elementor-widget-heading\" data-id=\"7ca8185\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Scope of Legal Action with Depo-Provera<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-76c6766 elementor-widget elementor-widget-text-editor\" data-id=\"76c6766\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>The legal landscape surrounding Depo-Provera litigation is expected to expand significantly in the coming years. Legal experts anticipate the formation of a Multi-District Litigation (MDL) in 2025, with projections suggesting approximately 30,000 cases will be filed against Pfizer. These cases primarily focus on the company&#8217;s failure to warn U.S. consumers about the risk of meningiomas, despite having knowledge sufficient to prompt warnings in other countries. The substantial number of expected cases reflects both the widespread use of Depo-Provera and the serious nature of the alleged health impacts. Hence, this effectuates legal intake centers to pursue\u00a0<a href=\"https:\/\/onpointlegalleads.com\/mass-tort-leads\/\" target=\"_blank\" rel=\"noopener\">mass tort lead generation<\/a>, which allows law firms to focus on helping patient-victims.<\/p><p>In the evolving landscape of contraceptive options, Depo-Provera has long stood as a popular choice for women seeking long-term birth control solutions. Recent statistics reveal its significant impact: approximately 24.5% of sexually active women in the United States used this injectable contraceptive between 2015 and 2019. However, new research has cast a shadow over its safety profile, prompting a closer examination of this widely-used medication.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c521d77 elementor-widget elementor-widget-heading\" data-id=\"c521d77\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">The Evolution of Depo-Provera Litigation: From Cancer Treatment to Contraceptive<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-677ea96 elementor-widget elementor-widget-image\" data-id=\"677ea96\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"1000\" height=\"593\" src=\"https:\/\/onpointlegalleads.com\/wp-content\/uploads\/2024\/11\/INH_19043_427017-e1732043245670.jpg\" class=\"attachment-full size-full wp-image-8738\" alt=\"Researcher examining laboratory samples, reflecting the scientific and legal complexities surrounding Depo-Provera litigation.\" srcset=\"https:\/\/onpointlegalleads.com\/wp-content\/uploads\/2024\/11\/INH_19043_427017-e1732043245670.jpg 1000w, https:\/\/onpointlegalleads.com\/wp-content\/uploads\/2024\/11\/INH_19043_427017-e1732043245670-300x178.jpg 300w\" sizes=\"(max-width: 1000px) 100vw, 1000px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-33f7ccf elementor-widget elementor-widget-heading\" data-id=\"33f7ccf\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Early Development and Initial Purpose<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-776c92b elementor-widget elementor-widget-text-editor\" data-id=\"776c92b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>The story of Depo-Provera begins in the 1950s in the\u00a0<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3464843\/\" target=\"_blank\" rel=\"noopener\">laboratories of Upjohn<\/a>\u00a0(now part of Pfizer). Initially developed as a treatment for endometrial and renal cancers, researchers discovered its contraceptive properties during clinical trials. This discovery would lead to decades of research, controversy, and eventual widespread adoption in family planning programs worldwide.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-66f3743 elementor-widget elementor-widget-heading\" data-id=\"66f3743\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">The Rocky Road to FDA Approval<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2fda559 elementor-widget elementor-widget-text-editor\" data-id=\"2fda559\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>As a quality\u00a0<a href=\"https:\/\/onpointlegalleads.com\/mass-tort-leads\/\" target=\"_blank\" rel=\"noopener\">mass tort lead generation company,<\/a>\u00a0we stay abreast of the path to FDA approval. And, the journey to FDA approval in the United States was notably complex and contentious. While other countries embraced the drug in the late 1960s, with France becoming one of the first to approve it in 1969, the U.S. maintained a more cautious stance. Multiple FDA\u00a0<span style=\"background-color: #ffffff; font-size: 17px;\">applications beginning in 1967 faced rejection due to concerns about potential cancer risks and other safety issues.<\/span><\/p><p style=\"font-size: 17px; background-color: #ffffff;\">This created an unusual situation where American women couldn&#8217;t access a contraceptive method that was widely available internationally. The FDA finally granted\u00a0<a style=\"font-size: 17px;\" href=\"https:\/\/www.washingtonpost.com\/archive\/politics\/1992\/10\/30\/fda-approves-depo-provera-an-injectable-contraceptive\/ba58a9e8-13aa-47d7-9282-ef6ac449fd76\/\" target=\"_blank\" rel=\"noopener\">approval in 1992<\/a>, following extensive safety studies and mounting evidence of its effectiveness from global usage data.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3c65589 elementor-widget elementor-widget-heading\" data-id=\"3c65589\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Understanding How Depo-Provera Works<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8842bdf elementor-widget elementor-widget-heading\" data-id=\"8842bdf\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">The Science Behind the Shot<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-01cfd6d elementor-widget elementor-widget-text-editor\" data-id=\"01cfd6d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Depo-Provera&#8217;s effectiveness relies on its active ingredient, medroxyprogesterone acetate, a synthetic version of the hormone progesterone. This hormone works through multiple mechanisms to prevent pregnancy:<\/p><ol><li><strong>Ovulation Suppression:<\/strong> The primary mechanism involves preventing the ovaries from releasing eggs<\/li><li><strong>Cervical Mucus Modification:<\/strong> The drug thickens cervical mucus, creating a barrier that sperm cannot easily penetrate<\/li><li><strong>Endometrial Changes:<\/strong> It alters the uterine lining, making it less hospitable for implantation<\/li><\/ol><p>Fallopian Tube Effects: The medication changes the movement of the fallopian tubes, affecting egg transport<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-087057c elementor-widget elementor-widget-heading\" data-id=\"087057c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Effectiveness and Administration<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a8470f5 elementor-widget elementor-widget-text-editor\" data-id=\"a8470f5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>When administered correctly every three months, Depo-Provera boasts an impressive effectiveness rate exceeding 99%. The injection must be given by a healthcare provider, typically in the arm or buttocks, and provides continuous contraception for 12-14 weeks.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-64e5903 elementor-widget elementor-widget-heading\" data-id=\"64e5903\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">The 2024 Health Crisis: New Research Reveals Serious Concerns<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4f66b9e elementor-widget elementor-widget-heading\" data-id=\"4f66b9e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Depo-Provera Litigation and the Groundbreaking Study<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-261531a elementor-widget elementor-widget-text-editor\" data-id=\"261531a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>March 2024 marked a pivotal moment in Depo-Provera&#8217;s history with the publication of a comprehensive study in the British Medical Journal. This research, analyzing data from 108,366 women, revealed a disturbing connection between Depo-Provera use and meningioma development. The study&#8217;s findings showed users were 5.55 times more likely to develop these brain tumors compared to non-users \u2013 a statistic that has sent shockwaves through the medical community. At On Point Legal Leads, we have been at the forefront of connecting law firms with individuals affected by such significant developments, ensuring attorneys have the\u00a0<a href=\"https:\/\/onpointlegalleads.com\/mass-tort-leads\/\" target=\"_blank\" rel=\"noopener\">mass tort case leads<\/a>\u00a0they need to advocate for victims and seek justice.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-42608c9 elementor-widget elementor-widget-heading\" data-id=\"42608c9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Historical Warning Signs<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-818bf9b elementor-widget elementor-widget-text-editor\" data-id=\"818bf9b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Perhaps most concerning is that early warning signs existed decades before this revelation. Research published in 1983 in the European Journal of Cancer &amp; Clinical Oncology had already identified high concentrations of progesterone receptors in meningioma cells. Additional studies in 1991 further demonstrated progesterone&#8217;s role in tumor development, yet these warnings didn&#8217;t lead to significant changes in prescribing practices or risk communications. Failing to warn about a reported\u00a0<a href=\"https:\/\/onpointlegalleads.com\/mass-tort-leads\/\" target=\"_blank\" rel=\"noopener\">mass tort leads<\/a>\u00a0to many patient-victims.\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-cd25bd3 elementor-widget elementor-widget-heading\" data-id=\"cd25bd3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Understanding Meningiomas: A Closer Look at the Risk<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-44ddbe2 elementor-widget elementor-widget-image\" data-id=\"44ddbe2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"2560\" height=\"1480\" src=\"https:\/\/onpointlegalleads.com\/wp-content\/uploads\/2024\/11\/Depo-Provera-Litigation-scaled-e1732057586885.jpg\" class=\"attachment-full size-full wp-image-8758\" alt=\"Meningiomas arise in the meninges, the protective layers of the brain and spinal cord. Learn about their three grades and how they affect treatment approaches and outcomes.\" srcset=\"https:\/\/onpointlegalleads.com\/wp-content\/uploads\/2024\/11\/Depo-Provera-Litigation-scaled-e1732057586885.jpg 2560w, https:\/\/onpointlegalleads.com\/wp-content\/uploads\/2024\/11\/Depo-Provera-Litigation-scaled-e1732057586885-300x173.jpg 300w, https:\/\/onpointlegalleads.com\/wp-content\/uploads\/2024\/11\/Depo-Provera-Litigation-scaled-e1732057586885-1024x592.jpg 1024w, https:\/\/onpointlegalleads.com\/wp-content\/uploads\/2024\/11\/Depo-Provera-Litigation-scaled-e1732057586885-1536x888.jpg 1536w, https:\/\/onpointlegalleads.com\/wp-content\/uploads\/2024\/11\/Depo-Provera-Litigation-scaled-e1732057586885-2048x1184.jpg 2048w\" sizes=\"(max-width: 2560px) 100vw, 2560px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-384d95a elementor-widget elementor-widget-heading\" data-id=\"384d95a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Types and Classifications<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-799f502 elementor-widget elementor-widget-text-editor\" data-id=\"799f502\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Meningiomas develop in the\u00a0<a href=\"https:\/\/www.mayoclinic.org\/diseases-conditions\/meningioma\/symptoms-causes\/syc-20355643\" target=\"_blank\" rel=\"noopener\">meninges<\/a>, the protective membranes surrounding the brain and spinal cord. These tumors are classified into three distinct grades, each with different implications for treatment and prognosis:<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c159c5f elementor-widget elementor-widget-heading\" data-id=\"c159c5f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Grade I Meningiomas (80% of cases)<span style=\"font-size: 19px\"><\/span><\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-516c290 elementor-widget elementor-widget-text-editor\" data-id=\"516c290\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li>Generally benign and slow-growing<\/li><li style=\"font-size: 17px;\">Often discovered incidentally during brain scans<\/li><li style=\"font-size: 17px;\">May not require immediate treatment if asymptomatic<\/li><li style=\"font-size: 17px;\">Better overall prognosis<\/li><li style=\"font-size: 17px;\">Can often be treated with surgery alone if necessary<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-64ecc42 elementor-widget elementor-widget-heading\" data-id=\"64ecc42\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Grade II Meningiomas (15% of cases)<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-378be31 elementor-widget elementor-widget-text-editor\" data-id=\"378be31\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li>Show more aggressive growth patterns<\/li><li>Higher likelihood of recurrence after treatment<\/li><li>Require more complex treatment approaches<\/li><li>May need combination therapy including surgery and radiation<\/li><li>Closer monitoring required post-treatment<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d0e72e8 elementor-widget elementor-widget-heading\" data-id=\"d0e72e8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Grade III Meningiomas (2% of cases)<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7165ba1 elementor-widget elementor-widget-text-editor\" data-id=\"7165ba1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li>Malignant and highly aggressive<\/li><li>Poor prognosis compared to lower grades<\/li><li>Require intensive treatment protocols<\/li><li>High risk of recurrence<\/li><li>May need chemotherapy in addition to surgery and radiation<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a18807d elementor-widget elementor-widget-heading\" data-id=\"a18807d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Depo-Provera Litigation: Legal Implications and Patient Rights<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-94fa373 elementor-widget elementor-widget-heading\" data-id=\"94fa373\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Current Legal Landscape<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ff1a470 elementor-widget elementor-widget-text-editor\" data-id=\"ff1a470\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>The emergence of these health risks has triggered significant\u00a0<a href=\"https:\/\/www.forbes.com\/advisor\/legal\/product-liability\/depo-provera-lawsuit\/\" target=\"_blank\" rel=\"noopener\">legal action against Pfizer<\/a>. The primary basis for litigation centers on the company&#8217;s alleged failure to adequately warn consumers about meningioma risks, despite decades of scientific evidence suggesting a connection. As <a href=\"https:\/\/onpointlegalleads.com\/mass-tort-leads\/\" target=\"_blank\" rel=\"noopener\">mass tort lead generation<\/a> experts, we empathize with claimants who\u2019ve suffered because of the alleged failure to warn about these risks.\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-130d3f6 elementor-widget elementor-widget-heading\" data-id=\"130d3f6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Eligibility for Depo-Provera Legal Action<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-cb3aeed elementor-widget elementor-widget-text-editor\" data-id=\"cb3aeed\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>To qualify for a Depo-Provera lawsuit, individuals typically may need to meet several criteria:<\/p><ul><li>Received at least two Depo-Provera injections after 1992<\/li><li>Diagnosed with a meningioma following Depo-Provera use<\/li><li>No current legal representation for this specific claim<\/li><li>Clear documentation of both Depo-Provera use and meningioma diagnosis<\/li><\/ul><p>For individuals who meet these criteria, On Point Legal Leads facilitates connections with experienced law firms specializing in Depo-Provera litigation.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0810538 elementor-widget elementor-widget-heading\" data-id=\"0810538\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Potential Compensation<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e04f5ff elementor-widget elementor-widget-text-editor\" data-id=\"e04f5ff\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>The Depo-Provera litigation has brought about legal experts projecting varying settlement values based on case severity:<\/p><ul><li>Basic cases with Grade I meningiomas: $275,000 to $350,000<\/li><li>Complex cases with Grade II meningiomas: $350,000 to $500,000<\/li><li>Severe cases with Grade III meningiomas: Potentially over $1 million<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-396b991 elementor-widget elementor-widget-heading\" data-id=\"396b991\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Healthcare Implications and Moving Forward with the Depo-Provera Litigation<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2b44375 elementor-widget elementor-widget-heading\" data-id=\"2b44375\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Guidelines for Current and Former Users<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9aab288 elementor-widget elementor-widget-text-editor\" data-id=\"9aab288\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>If you&#8217;ve used Depo-Provera, you may consider taking these important steps:<\/p><ol><li>Medical Consultation<\/li><li>Schedule an appointment with your healthcare provider<\/li><li>Discuss your personal risk factors<\/li><li>Create a monitoring plan if needed<\/li><li>Explore alternative contraceptive options<\/li><li>Symptom Awareness<\/li><li>Learn to recognize potential meningioma symptoms<\/li><li>Monitor for persistent headaches<\/li><li>Watch for vision changes<\/li><li>Note any unusual neurological symptoms<\/li><li style=\"font-size: 17px;\">Documentation<\/li><li style=\"font-size: 17px;\">Maintain records of your Depo-Provera use<\/li><li style=\"font-size: 17px;\">Keep copies of medical records<\/li><li style=\"font-size: 17px;\">Document any symptoms or concerns<\/li><li style=\"font-size: 17px;\">Save all related medical correspondence<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-db7e932 elementor-widget elementor-widget-heading\" data-id=\"db7e932\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Future Considerations for Healthcare Providers<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f20b353 elementor-widget elementor-widget-text-editor\" data-id=\"f20b353\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>The Depo-Provera controversy has prompted medical professionals to reassess their approach to contraceptive counseling. Key considerations include:<\/p>\n<ol>\n<li>Risk Assessment<\/li>\n<li>More thorough patient screening<\/li>\n<li>Detailed family history evaluation<\/li>\n<li>Regular monitoring protocols<\/li>\n<li>Enhanced informed consent processes<\/li>\n<li>Alternative Options<\/li>\n<li>Discussion of other contraceptive methods<\/li>\n<li>Individualized approach to birth control choices<\/li>\n<li>Regular reassessment of contraceptive needs<\/li>\n<li>Consideration of non-hormonal options<\/li>\n<\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-041b4c6 elementor-widget elementor-widget-heading\" data-id=\"041b4c6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Conclusion<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-21b9cf3 elementor-widget elementor-widget-text-editor\" data-id=\"21b9cf3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>The\u00a0<a href=\"https:\/\/www.nwhjournal.org\/article\/S1091-5923(15)31331-5\/fulltext\" target=\"_blank\" rel=\"noopener\">Depo-Provera controversy<\/a>\u00a0serves as a crucial reminder of the complex balance between contraceptive access and safety. While it remains an effective birth control option, the newly discovered risks demand careful consideration and ongoing monitoring. For current and former users, staying informed and maintaining open communication with healthcare providers is essential.<\/p><p>As research continues and legal proceedings advance, our understanding of Depo-Provera&#8217;s long-term effects will likely evolve. And our\u00a0<a href=\"https:\/\/onpointlegalleads.com\/mass-tort-leads\/\" target=\"_blank\" rel=\"noopener\">mass tort leads<\/a>\u00a0will reflect these changes. This situation highlights the critical importance of post-market drug surveillance and the need for\u00a0<span style=\"background-color: #ffffff; font-size: 17px;\">transparent communication about medical risks. For now, individuals must work closely with their healthcare providers to make informed decisions about their contraceptive choices, weighing both the benefits and potential risks of all available options.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a567d67 elementor-widget elementor-widget-heading\" data-id=\"a567d67\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Why Choose On Point Legal Leads for Your Depo-Provera Mass Tort Leads and Your Depo-Provera Mass Tort Signed Retainers?<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f12d995 elementor-widget elementor-widget-text-editor\" data-id=\"f12d995\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>At On Point Legal Leads, we understand the critical nature of the Depo-Provera litigation and the importance of connecting affected individuals with skilled legal representation. We specialize in delivering thoroughly vetted, high-quality mass tort leads and signed retainers that meet all current litigation criteria.\u00a0<\/p><p>Our rigorous verification process ensures each lead has documented Depo-Provera usage and a confirmed meningioma diagnosis, saving your firm valuable time and resources.<\/p><p>Ready to strengthen your Depo-Provera litigation portfolio and help affected individuals seek justice?\u00a0<\/p><p>Contact On Point Legal Leads today to learn how our\u00a0<a href=\"https:\/\/onpointlegalleads.com\/mass-tort-leads\/\" target=\"_blank\" rel=\"noopener\">premium mass tort leads<\/a>\u00a0can help grow your practice efficiently and effectively.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d1759dd elementor-widget elementor-widget-text-editor\" data-id=\"d1759dd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><sup>1<\/sup> <i>&nbsp;<\/i>Roberts, D. E., &amp; Jesudason, S. (2011). <i>Racism and disparities in women\u2019s use of the Depo-Provera injection in the contemporary USA. <\/i>Critical Sociology, 37(5), 673-688.&nbsp;<a style=\"font-size: 14px;\" href=\"https:\/\/doi.org\/10.1177\/0896920510380948\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.1177\/0896920510380948<\/a><br><sup>2<\/sup>&nbsp;Smith, D. G. (2017).&nbsp;<i>Resolution of Common Questions in MDL Proceedings.<\/i>&nbsp;University of Kansas Law Review, 66, 219. Retrieved from HeinOnline:&nbsp;<a href=\"https:\/\/heinonline.org\/HOL\/Page?handle=hein.journals\/ukalr66&amp;div=11\" target=\"_blank\" rel=\"noopener\">https:\/\/heinonline.org\/HOL\/Page?handle=hein.journals\/ukalr66&amp;div=11<\/a><br><sup>3<\/sup>&nbsp;Kavanaugh, M. L., &amp; Pliskin, E. (2020).&nbsp;<i>Use of contraception among reproductive-aged women in the United States, 2014 and 2016.&nbsp;<\/i>F&amp;S Reports, 1(2), 83-93.&nbsp;<a href=\"https:\/\/doi.org\/10.1016\/j.xfre.2020.05.010\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.1016\/j.xfre.2020.05.010<\/a><br><sup style=\"background-color: transparent;\">4<\/sup><span style=\"font-size: 14px;\"> Organization of Teratology Information Specialists (OTIS). (2023). <\/span><i style=\"font-size: 14px;\">Depot Medroxyprogesterone Acetate (Depo-Provera\u00ae).<\/i><span style=\"font-size: 14px;\"> Mother To Baby | Fact Sheets. Brentwood, TN. Retrieved from <\/span><a style=\"font-size: 14px;\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK582820\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK582820\/<\/a><br><sup style=\"background-color: transparent;\">5<\/sup><span style=\"font-size: 14px;\"> WebMD Editorial Contributors. (2024, January 14). Birth Control Shot: Depo-Provera (Medroxyprogesterone). Medically reviewed by Zilpah Sheikh, MD. WebMD. Retrieved from <\/span><a style=\"font-size: 14px;\" href=\"https:\/\/www.webmd.com\/sex\/birth-control\/birth-control-Depo-Provera\" target=\"_blank\" rel=\"noopener\">https:\/\/www.webmd.com\/sex\/birth-control\/birth-control-Depo-Provera<\/a><br><sup style=\"background-color: transparent;\">6<\/sup><span style=\"font-size: 14px;\"> Blankenstein, M. A., et al. (1983). <\/span><i style=\"font-size: 14px;\">Presence of progesterone receptors and absence of estrogen receptors in human intracranial meningioma cytosols.<\/i><span style=\"font-size: 14px;\"> European Journal of Cancer and Clinical Oncology, 19(3), 365-370. <\/span><a style=\"font-size: 14px;\" href=\"https:\/\/doi.org\/10.1016\/0277-5379(83)90134-7\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.1016\/0277-5379(83)90134-7<\/a><br><sup style=\"background-color: transparent;\">7<\/sup><span style=\"font-size: 14px;\"> Durand, A., Labrousse, F., Jouvet, A., Bauchet, L., Kalamarid\u00e8s, M., Menei, P., &amp; Guyotat, J. (2009). <\/span><i style=\"font-size: 14px;\">WHO grade II and III meningiomas: A study of prognostic factors.<\/i><span style=\"font-size: 14px;\"> Journal of Neuro-Oncology, 95, 367-375. <\/span><a style=\"font-size: 14px;\" href=\"https:\/\/doi.org\/10.1007\/s11060-009-9934-0\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.1007\/s11060-009-9934-0<\/a><br><sup style=\"background-color: transparent;\">8<\/sup><span style=\"font-size: 14px;\"> Glasier, A., Yan, Y., &amp; Wellings, K. (2007). <\/span><i style=\"font-size: 14px;\">How do health care professionals respond to advice on adverse side effects of contraceptive methods? The case of Depo-Provera\u00ae. <\/i><span style=\"font-size: 14px;\">Contraception, 75(6), 460-467. <\/span><a style=\"font-size: 14px;\" href=\"https:\/\/doi.org\/10.1016\/j.contraception.2007.03.002\" target=\"_blank\" rel=\"noopener\">https:\/\/doi.org\/10.1016\/j.contraception.2007.03.002<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-2f10cee elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"2f10cee\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t\t<div class=\"elementor-background-overlay\"><\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-3e3e281\" data-id=\"3e3e281\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-8b7e053 elementor-align-center elementor-widget elementor-widget-button\" data-id=\"8b7e053\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"tel:9723335114\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-long-arrow-alt-right\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Let's Talk Today!<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>At On Point Legal Leads, we specialize in providing law firms with the highest quality Depo-Provera litigation mass tort leads and mass tort retainers leads. Our commitment to connecting affected individuals with experienced legal representation has positioned us at the forefront of this emerging litigation.<\/p>\n<p>Let\u2019s dive into the details of this significant health and legal issue.<\/p>\n","protected":false},"author":1,"featured_media":8757,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-8685","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mass-tort-leads"],"_links":{"self":[{"href":"https:\/\/onpointlegalleads.com\/wp-json\/wp\/v2\/posts\/8685","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/onpointlegalleads.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/onpointlegalleads.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/onpointlegalleads.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/onpointlegalleads.com\/wp-json\/wp\/v2\/comments?post=8685"}],"version-history":[{"count":0,"href":"https:\/\/onpointlegalleads.com\/wp-json\/wp\/v2\/posts\/8685\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/onpointlegalleads.com\/wp-json\/wp\/v2\/media\/8757"}],"wp:attachment":[{"href":"https:\/\/onpointlegalleads.com\/wp-json\/wp\/v2\/media?parent=8685"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/onpointlegalleads.com\/wp-json\/wp\/v2\/categories?post=8685"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/onpointlegalleads.com\/wp-json\/wp\/v2\/tags?post=8685"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}